Back
ESC2025 Premium Access

Suboptimal lipid measurement and statin use after percutaneous coronary intervention according to socioeconomic status and ethnicity: a subanalysis of the DISCOVER registry

Session: Secondary prevention (1)
Topic: Secondary Prevention
Speaker: Doctor F. Bruno (Turin, IT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Francesco Bruno

Hospital Molinette of the University Hospital S. Giovanni Battista, Turin (Italy)
0 follower

6 more presentations in this session

Cholesterol and risk of ST-segment elevation versus non-ST-segment elevation myocardial infarction: a population-based cohort study

Speaker: Professor M. Maeng (Aarhus, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Which feature of the metabolic syndrome is better predictor for coronary artery disease morbidity and mortality; a prospective 10-year analysis

Speaker: Associate Professor L. Bikdelu (Mashhad, IR)

Access
Abstract
Slides
Video
Like
Thumbnail

Low dose colchicine for secondary prevention in patients with previous atherosclerotic event: a systematic review and meta-analysis of randomised trials

Speaker: Doctor R. Barbosa Sousa (Lisbon, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment

Speaker: Doctor P. Tonnesen (Aarhus, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Enhancing the precision of lipid management quality assessment in ASCVD using large language models

Speaker: Doctor D. Nguyen (Dallas, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Secondary prevention (1)

Speakers: Doctor F. Bruno, Professor M. Maeng, Associate Professor L. Bikdelu, Doctor R. Barbosa Sousa, Doctor P. Tonnesen...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources